Bottom line
How much do FPHAX and IHE overlap?
40% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 48.0% of FPHAX's assets and 58.7% of IHE's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FPHAX and IHE have in common
| Holding | % of FPHAX | % of IHE | Overlap |
|---|---|---|---|
| ELI LILLY and CO | 28.78% | 22.25% | 22.25% |
| Viatris Inc | 5.45% | 4.22% | 4.22% |
| MERCK and CO INC | 4.74% | 4.55% | 4.55% |
| Elanco Animal Health Inc | 4.15% | 2.81% | 2.81% |
| JOHNSON and JOHNSON | 3.77% | 22.44% | 3.77% |
| Axsome Therapeutics Inc | 1.08% | 2.42% | 1.08% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FPHAX
- Gsk Plc — 8.17%
- Ucb Sa — 5.09%
- Roche Holding Ag — 4.54%
- Legend Biotech Corp — 4.53%
- Astrazeneca Plc — 4.22%
- Jazz Pharmaceuticals Plc — 4.09%
- Gilead Sciences Inc — 3.97%
- Royalty Pharma Plc — 2.67%
- Fidelity Revere Street Trust — 2.44%
- Moderna Inc — 1.57%
- Intellia Therapeutics Inc — 1.19%
- Beam Therapeutics Inc — 1.10%
- Biontech Se — 1.04%
- Xenon Pharmaceuticals Inc — 0.82%
- Ocular Therapeutix Inc — 0.80%
Only in IHE
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
- Bristol-myers Squibb Company — 4.37%
- Royalty Pharma Plc — 4.34%
- Pfizer Inc. — 3.96%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
- Corcept Therapeutics Incorporated — 1.90%
- Ligand Pharmaceuticals Incorporated — 1.45%
- Definium Therapeutics Inc — 1.39%
- Liquidia Corp — 1.28%
- Indivior Pharmaceuticals, Inc. — 1.14%
- Crinetics Pharmaceuticals Inc — 0.90%
- Organon & Co. — 0.81%
- Edgewise Therapeutics Inc — 0.70%
- Amneal Pharmaceuticals, Inc. — 0.68%
Asset mix
| Asset type | FPHAX | IHE |
|---|---|---|
| Stocks | 98.7% | 99.9% |
| Cash & short-term funds | 2.6% | 6.3% |
| Preferred stock | 0.7% | — |
| Bonds | 0.1% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Country mix
| Country | FPHAX | IHE |
|---|---|---|
| US | 64.8% | 96.4% |
| GB | 15.1% | 4.3% |
| BE | 5.3% | — |
| CH | 4.5% | — |
| KY | 4.5% | 0.2% |
| IE | 4.1% | 3.8% |
| CA | 1.1% | 1.4% |
| DE | 1.0% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FPHAX and IHE overlap?
What stocks do FPHAX and IHE have in common?
Should I own both FPHAX and IHE?
Which holds more stocks, FPHAX or IHE?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.